Biotie has started the first phase I clinical trial with its fully human VAP-1 monoclonal antibody as it has received the final regulatory approval to do so
News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe![Newsletter La Merie Biologics](https://pipelinereview.com/wp-content/uploads/2024/02/newsletter-1.png)
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe![Newsletter new product alert](https://pipelinereview.com/wp-content/uploads/2024/02/report-alert.png)
Featured reports